Asian Journal of Traditional Medicines ›› 2019, Vol. 14 ›› Issue (6): 268-279.

Previous Articles     Next Articles

The progress and related pharmacological mechanism of hyperlipidemia treatment

Zhaohui Ren, Jianxiu Zhai, Na Han, Zhihui Liu, Jun Yin *   

  1. School of Traditional Chinese Materia, Shenyang Pharmaceutical University; Shenyang 110016, China
  • Received:2019-06-13 Accepted:2019-11-26 Online:2019-12-20 Published:2020-01-02
  • Contact: Shenyang Pharmaceutical University 103 Wenhua Road, Shenhe district; Tel: +86-24-23986491; fax: +86-24-23986460; E-mail address: yinjun826@sina.com. E-mail:yinjun826@sina.com

Abstract: Hyperlipidemia (HLP) is a long-known risk factor for a series of cardiovascular and cerebrovascular diseases, such as atherosclerosis, coronary heart disease, hypertension and so on. With its increasing incidence, the prevention and treatment of HLP has also become an important research topic around the world. Traditional Chinese medicine (TCM) has been used to treat HLP for a long time with its better therapeutic efficacy, less side effects and wider indications compared with western medicine. In this review, we summarized the pathogenesis of HLP, the research situation of disease-related targets, and the treatment progress of TCM by conducting literature research and sorting out relevant information, in order to provide reference for further research of HLP and prevent the occurrence of cardiovascular and cerebrovascular diseases.

Key words: HLP, TCM, targets, treatment progress, pathogenesis

Trendmd